Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Results found: 5

first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  dyslipidemia
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Publication available in full text mode
Content available

Analiza częstości występowania poszczególnych zaburzeń lipidowych wśród pacjentów z rozpoznaną dyslipidemią

100%
Gwiazda E., Mastalerz-Migas A., Szyber P.
Family Medicine & Primary Care Review
|
2014
|
issue 2
101-102
PL
Wstęp. Choroby sercowo-naczyniowe odpowiadają za 45% zgonów w Polsce. Umierają na nie głównie osoby po 65. roku życia, ale są obecne już u osób znacznie młodszych. ajczęstszym czynnikiem ryzyka chorób sercowo-naczyniowych jest dyslipidemia. Cel pracy. Oszacowanie częstości występowania poszczególnych rodzajów zaburzeń lipidowych przed rozpoczęciem leczenia wśród pacjentów z rozpoznaną dyslipidemią w zależności od wieku. Materiał i metody. Badanie przeprowadzono na podstawie wypełnionych przez lekarzy pracujących w opiece ambulatoryjnej w Polsce anonimowych kwestionariuszy dotyczących dorosłych pacjentów z rozpoznaną dyslipidemią. Do badania akwalifikowano 23 136 pacjentów. Badanie przeprowadzono w latach 2009–2010. Wyniki. Nieprawidłowe stężenie cholesterolu całkowitego (TC) przed rozpoczęciem leczenia wykazano u 94% osób z podanymi wartościami parametru, LDL -C odpowiednio u 91,5%, HDL -C – u 37%, natomiast trójglicerydów (TG) – u 68,1%.TC najczęściej zaburzony był w grupie osób < 45. r.ż., LDL -C w grupie wiekowej 45–54 lata, HDL -C u osób < 65. r.ż., a T G w grupie 55–64 lata. Wnioski. Stężenia poszczególnych składowych lipidogramu zależą od wieku. Najbardziej zintensyfikowane działania, mające na celu identyfikację osób z dyslipidemią i ich skuteczne leczenie, powinny być skierowane do osób poniżej 65. r.ż.
2
Publication available in full text mode
Content available

Czynniki ryzyka sercowo-naczyniowego a częstość występowania zespołu metabolicznego w grupie dzieci i młodzieży

100%
Banaś I., Lewek P.
Family Medicine & Primary Care Review
|
2015
|
issue 2
79-81
3
Publication available in full text mode
Content available

Akromegalia – niedoceniony problem zdrowotny w praktyce lekarza rodzinnego

88%
Zieleniewski W., Michalak R.
Family Medicine & Primary Care Review
|
2011
|
issue 2
273-275
4
Publication available in full text mode
Content available

Prevention and nutritional therapy of metabolic syndrome

88%
Rożniata M., Zujko K., Zujko, M.E
Progress in Health Sciences
|
2017
|
vol. 7(2)
100-104
EN
The term metabolic syndrome (MetS) defines the cooccurrence of the related risk factors of metabolic origin that promote the development of cardiovascular diseases with atherosclerotic background and type 2 diabetes. The diagnostic criteria of MetS have undergone modifications for years. Until now no clear definition of MetS has been established. The latest diagnostic criteria of MetS published in 2009 by a group of IDF (International Diabetes Federation) and AHA/NHLBI (American Heart Association/ National Heart, Lung and Blood Institute) experts discern three out of five risk factors: abdominal obesity (taking into consideration population differences), elevated level of triglycerides, reduced HDL cholesterol, hypertension and fasting hyperglycemia. Genetic predispositions and environmental factors, such as lack of physical activity and improper diet are considered to be responsible for MetS development. Therefore, prevention and treatment of MetS should be based first of all on a change in modifiable lifestyle factors, among which proper diet is of essential importance.
5
Publication available in full text mode
Content available

The analysis of screening costs for hypercholesterolemia and hyperglycemia as part of obligatory examinations of employees

75%
Marcinkiewicz A., Olejniczak D., Śliż D., Staniszewska A.
International Journal of Occupational Medicine and Environmental Health
|
2021
|
vol. 34
|
issue 5
581-589
EN
ObjectivesHigh prevalence of hyperlipidemia and hyperglycemia requires searching for efficient and cost-effective methods of an early detection of these disorders. In Poland, obligatory employee medical check-ups could be a solution.Material and MethodsThe study included a group of university employees who underwent obligatory occupational examinations in 2018. Each employee had an additional lipid (unit cost: EUR 2.56) and blood glucose profile (EUR 0.93) done. The number of respondents involved in the study was 850 (340 males and 510 females), and their average age was 47 years (SD = 11 years). The education distribution was as follows: employees with secondary vocational and general education (physical, frontline and administrative workers): 176 (age: M±SD 50.3±10.3); employees with a university degree (academics with an M.Sc. or/and Ph.D. title and administrative staff): 535 (age: M±SD 43.6±9.8); and academics with a university title (Ass. Prof. and/or Prof.): 139 (age: M±SD 56.2±10.2).ResultsDyslipidemia (elevated total cholesterol ≥190 mg/dl and/or low-density lipoprotein cholesterol ≥115 mg/dl) was reported in 560 workers (65.9%). Hyperglycemia (fasting glucose ≥100 mg/dl) was observed in 256 workers (31%). The total cost of detecting a single case of dyslipidemia and hyperglycemia was EUR 3.88 and EUR 3.09, respectively. Divided by age groups, the costs were as follows: EUR 4.34 and EUR 4.53 in the age group <45 years; EUR 3.56 and EUR 2.42 in the age group ≥45 years. The costs of detecting a single case of dyslipidemia and hyperglycemia in employees aged ≥45 with regard to education were as follows: EUR 3.20 and EUR 2.07 in persons with secondary vocational and general education; EUR 3.40 and EUR 2.80 in persons with a university degree; and EUR 4.38 and EUR 2.28 in persons with a university title.ConclusionsDue to the fact that the reporting rate for screening tests in the framework of occupational medicine is high, the cost of occupational screening tests for dyslipidemia and hyperglycemia can be lower than the cost of screening tests in the general population.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.